Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mendes

Showing results (221-230 of 473) with videos related to

Pageof 48
Sort By:
Journal of Chromatography. A|July 14, 2004
Analysis of heterocyclic aromatic amines in foods by gas chromatography-mass spectrometry as their tert.-butyldimethylsilyl derivativesS Casal, E Mendes, J O Fernandes, et al.
Diagnostic Microbiology and Infectious Disease|March 22, 2013
Contemporary potencies of minocycline and tetracycline HCL tested against Gram-positive pathogens: SENTRY Program results using CLSI and EUCAST breakpoint criteriaRonald N Jones, Michael L Wilson, Melvin P Weinstein, et al.
Diagnostic Microbiology and Infectious Disease|March 13, 2013
An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011Robert K Flamm, Rodrigo E Mendes, James E Ross, et al.
Antimicrobial Agents and Chemotherapy|December 11, 2013
Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United StatesRodrigo E Mendes, Robert K Flamm, Patricia A Hogan, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 30, 2019
<i>In Vitro</i> Activity of Tedizolid in Comparison with Other Oral and Intravenous Agents Against a Collection of Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> (2014-2015) in the United StatesMichael A Pfaller, Helio S Sader, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Oritavancin Activity Tested against Molecularly Characterized Staphylococci and Enterococci Displaying Elevated Linezolid MIC ResultsRodrigo E Mendes, David J Farrell, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy|March 26, 2016
Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility ratesRodrigo E Mendes, Patricia A Hogan, Ronald N Jones, et al.
Journal of Global Antimicrobial Resistance|July 24, 2017
Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014)Leonard R Duncan, Helio S Sader, Jennifer I Smart, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2014
Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing methodRodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2017
Five-Year Summary of <i>In Vitro</i> Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015)Michael A Pfaller, Rodrigo E Mendes, Jennifer M Streit, et al.
Pageof 48

Showing results (221-230 of 473) with videos related to

Sort By:
Pageof 48
Journal of Chromatography. A|July 14, 2004
Analysis of heterocyclic aromatic amines in foods by gas chromatography-mass spectrometry as their tert.-butyldimethylsilyl derivativesS Casal, E Mendes, J O Fernandes, et al.
Diagnostic Microbiology and Infectious Disease|March 22, 2013
Contemporary potencies of minocycline and tetracycline HCL tested against Gram-positive pathogens: SENTRY Program results using CLSI and EUCAST breakpoint criteriaRonald N Jones, Michael L Wilson, Melvin P Weinstein, et al.
Diagnostic Microbiology and Infectious Disease|March 13, 2013
An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011Robert K Flamm, Rodrigo E Mendes, James E Ross, et al.
Antimicrobial Agents and Chemotherapy|December 11, 2013
Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United StatesRodrigo E Mendes, Robert K Flamm, Patricia A Hogan, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 30, 2019
<i>In Vitro</i> Activity of Tedizolid in Comparison with Other Oral and Intravenous Agents Against a Collection of Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> (2014-2015) in the United StatesMichael A Pfaller, Helio S Sader, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Oritavancin Activity Tested against Molecularly Characterized Staphylococci and Enterococci Displaying Elevated Linezolid MIC ResultsRodrigo E Mendes, David J Farrell, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy|March 26, 2016
Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility ratesRodrigo E Mendes, Patricia A Hogan, Ronald N Jones, et al.
Journal of Global Antimicrobial Resistance|July 24, 2017
Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014)Leonard R Duncan, Helio S Sader, Jennifer I Smart, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2014
Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing methodRodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2017
Five-Year Summary of <i>In Vitro</i> Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015)Michael A Pfaller, Rodrigo E Mendes, Jennifer M Streit, et al.
Pageof 48